StockGuru Welcomes Vicor Technologies, Inc. (OTCBB: VCRT) – StockGuru Level I Trade Idea
StockGuru Welcomes Vicor Technologies, Inc. (OTCBB: VCRT)
Vicor Technologies, Inc. (OTCBB: VCRT)
LEVEL 1 TRADE IDEA
Dear Members,
Rather than call this the last great trade idea of 2009, I am going to call this one one of the best trade ideas for all of 2010. I put this in my top category of stocks you must be looking at for 2010.
I have tried to concentrate during 2009 on companies that are truly cutting edge and truly possess something unique no other company really has.
You have seen this with Medizone International (MZEI), Skinvisible, Inc. (SKVI) and a few others I have let you know I totally believe in. Vicor Technologies, Inc. is one of those companies.
The trading symbol is VCRT. It is a fully reporting Bulletin Board stock.
I have assigned it my “Level 1 Trade Idea – Bulletin Board” rating. What that means is I see this company in a very unique category. This means it is in my highest rating for a Bulletin Board stock.
I encourage you to read our introduction below, and then our full profile on StockGuru.com – READ IT HERE.
Thank you,
John Pentony
Publisher, StockGuru.com
Introduction
Vicor Technologies, Inc. (OTCBB: VCRT) is in the crucial transformative stage for a biotechnology company on the verge of becoming a viable commercial enterprise.
This biotechnology company is focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i™ nonlinear algorithm and software which is:
- Highly accurate
- Provides user friendly data acquisition
- Effective for trauma triage easily deployed in a portable monitor
- Provides a simple noninvasive test for identifying patients at risk of sudden cardiac death
- Provides a simple noninvasive test for identifying patients with Diabetic Autonomic Neuropathy
The PD2i Algorithm and software risk stratifies target populations to predict future pathological events. As a predictor of sudden cardiac death it has been shown to be highly accurate, with a sensitivity approaching 100% and a specificity of ~86%.
The advantage of the PD2i™ nonlinear algorithm is that it typically uses recordings made at rest and does not require stress-testing or any active participation from the patient. The test is relatively impervious to data non-stationarities and artifacts, setting it apart from other measures with unparalleled sensitivity.
A large physician shareholder base represents the early adoptees of this Company.
Vicor’s PD2i™ Nonlinear Algorithm is:
- A new vital sign with the ability to actually save lives in both combat and civilian setting
- The PD2i Analyzer™ can capture and display Heart Rate Variability (see defined below) in patients at rest and during paced respiration and controlled exercise.
- Able to identify trauma victims in need of an immediate lifesaving intervention
- Able to be used along with other clinical data to identify patients at risk of sudden cardiac death
- Able to be used along with other clinical data to identify patients who have autonomic dysfunction
- Able to improve trauma triage in real world situations and on the battlefield where time is of the essence and the collection of ‘clean’ data is never guaranteed
- Able to provide consistently accurate results which requires just one to two minutes of EKG data in a trauma setting
- Not derailed in delivering actionable results by noisy raw EKG data
- Functional in trauma environments and battlefield situations
READ THE FULL STOCKGURU PROFILE HERE:
http://www.stockguru.com/about/vicor/
Pentony Enterprises LLC is STOCKGURU.COM. 10604 Robincreek Lane; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated fifty thousand restricted common shares and seventy-two hundred dollars by the company for profile coverage for the period ending March 31, 2010. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We will not be buying or selling shares of Vicor during the promotional period.
